Geron Corp (NASDAQ:GERN)’s traded shares stood at 2.1 million during the last session, with the company’s beta value hitting 0.49. At the last check today, the stock’s price was $3.68, to imply a decrease of -0.81% or -$0.03 in intraday trading. The GERN share’s 52-week high remains $5.34, putting it -45.11% down since that peak but still an impressive 55.43% since price per share fell to its 52-week low of $1.64. The company has a valuation of $2.22B, with an average of 12.65 million shares in intraday trading volume over the past 10 days and average of 8.28 million shares over the past 3 months.

Analysts have given a consensus recommendation of Buy for Geron Corp (GERN), translating to a mean rating of 1.10. Of 5 analyst(s) looking at the stock, 0 analyst(s) give GERN a Sell rating. 0 of those analysts rate the stock as Overweight while 1 advise Hold as 4 recommend it as a Buy. 0 analyst(s) have given it an Underweight rating. Estimates put the company’s current-quarter earnings per share at -0.05.

Geron Corp (NASDAQ:GERN) trade information

After registering a -0.81% downside in the latest session, Geron Corp (GERN) has traded red over the past five days. The 5-day price performance for the stock is -13.41%, and -9.36% over 30 days. With these gigs, the year-to-date price performance is 74.41%. Short interest in Geron Corp (NASDAQ:GERN) saw shorts transact 76.24 million shares and set a 11.2 days time to cover.

The extremes give us $4.5 and $8 for target low and target high price respectively. As such, GERN has been trading -117.39% off suggested target high and -22.28% from its likely low.

Geron Corp (GERN) estimates and forecasts

Looking at statistics comparing Geron Corp share performance against respective industry, we note that the company has outperformed competitors. Geron Corp (GERN) shares are -3.41% down over the last 6 months, with its year-to-date growth rate higher than industry average at 21.88% against 17.70%. Revenue is forecast to grow 44.17% this quarter before jumping 58.00% for the next one. The rating firms project that company’s revenue will grow 32,363.11% compared to the previous financial year.

Revenue forecast for the current quarter as set by 7 analysts is 47.56M. Meanwhile, for the current quarter, a total of 6 analyst(s) estimate revenue growth to 55.83M.Earnings reports from the last fiscal year show that sales brought in 23k and 304k respectively in the corresponding quarters. In this case, analysts estimate current quarter sales to rise 206,672.05% before jumping 18,263.71% in the following quarter.

An assessment of the company’s 5-year growth patterns shows that annual earnings shrunk an estimated -16.08% for the past 5-year period. While 2024 is set for a 17.85% return in earnings, projections for the next 5 years are at 5.00% annually.

GERN Dividends

Geron Corp has its next earnings report out on 2025-Feb-26. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too.

Geron Corp (NASDAQ:GERN)’s Major holders

Geron Corp insiders hold 0.09% of total outstanding shares, with institutional holders owning 85.36% of the shares at 85.43% float percentage. In total, 85.36% institutions holds shares in the company, led by BLACKROCK INC.. As of 2024-06-30, the company held over 46.55 million shares (or 7.7138% of shares), all amounting to roughly $197.38 million.

The next major institution holding the largest number of shares is RA CAPITAL MANAGEMENT, L.P. with 46.2 million shares, or about 7.6558% of shares outstanding. As of the market price on 2024-06-30, these shares were worth $195.9 million.